The vision of MetaHeps is to increase access of patients to novel drugs by addressing DILI issues in drug development in an unrivaled and innovative approach:

Using our patented technology will

MetaHeps is a spin-off of the university hospital Grosshadern Munich, germany.

Founded in 2014, the aim of MetaHeps is to provide innovative solutions to the challenge of idiosyncratic drug-induced liver injury in clinical drug development.

Economic Milestones Scientific Milestones
08/12 EXIST Technology Transfer Grant (German Federal Ministry of Technology) Publication of proof-of-concept technology
07/13 Winner Science4Life Businessplan Competition m^4-Award for research excellence in personalized medicine (Bavarian Ministry of Technology)
03/14 Metaheps GmbH founded
10/14 US-Patent granted DILI - Workshop, Freiburg, Germany
03/15 Presentation XV. FDA-DILI Conference
06/15 EU Patent granted Publication of first results from the pilot study in the journal Gut
11/15 Funding by Horizon 2020 SME-Instruments Phase I (DILITEST)
04/16 Start of collaboration with industry partner (nanion GmbH) Start of collaboration with Pro-Euro-DILI Network
05/16 Entrance FDA Biomarker Qualification program
06/16 Start of negotiations with pilot customers Invited presentation at the AASLD Hepatotoxicity SIG webinar
07/16 Funding of EIT Health Head Start Program
08/16 Japan patent granted
03/17 Quality Management System certification according to DIN EN ISO 9001:2015 Review on DILI published in the journal Gut highlighting the MetaHeps test
04/17 Funding by BayTOU (Bavarian Ministry of Technology) Start of collaboration with Chinese University Hong Kong
06/17 Funding by Permides (EIT Health) Start of collaboration University Malaga
02/18 Founding Member of GAME – INDILIR University Network
03/18 First Data on DDI in MetaHeps published
04/18 Validation MH Test for Drug Causality published
04/18 COST Application Pro-Euro-DILI Network granted
05/18 Stakeholder H 2020 IMI-Transbioline Consortium
06/18 Proof-of-concept MH based biomarker published
11/18 First Japanese samples received and successfully tested
03/19 Presentation Pro-EURO DILI Network Meeting in Malaga